Category: Research & Development
Research & Development market research reports by Euromonitor International
-
Cannabis in the Czech Republic
Cannabis in the Czech Republic The cannabis market in the Czech Republic is poised for significant changes in 2025, driven by evolving legislation and shifting economic and demographic factors. Recent developments indicate that the initial ambitious plans to establish a legal commercial market for c ... Read More
-
Cannabis in the Netherlands
Cannabis in the Netherlands In 2024, the Dutch cannabis market continued to face economic challenges, although conditions showed some improvement compared to 2023. Inflation eased significantly but remained a concern, leading to cautious consumer spending habits. While price increases for CBD were m ... Read More
-
Cannabis in Switzerland
Cannabis in Switzerland Overall, demand for cannabis remained strong in Switzerland during 2024. Cannabis registered significant value sales growth throughout the year. The main reason for the strong growth was the excellent performance of adult-use cannabis. Adult-use cannabis recorded the fastest ... Read More
-
Cannabis in Japan
Cannabis in Japan Currently, the medical cannabis market is very limited in Japan, but the illegal cannabis market is growing along with the legal CBD market. In 1948, Japan’s Cannabis Control Act prohibited cannabis use, restricting its cultivation to purposes such as fibre, seeds and research, und ... Read More
-
Cannabis in Greece
Cannabis in Greece Greece has been historically a small cannabis market comprised of an overwhelming share of illicit value sales and a small percentage of CBD sales, whereas medical and adult-use cannabis products were not allowed. Despite scope being rather limited in 2024, the introduction of med ... Read More
-
Cannabis in Portugal
Cannabis in Portugal Prescriptions of medical cannabis remain low in Portugal. However, 2024 was marked by the introduction of five new cannabis-based medications, including one flower and four different oral solutions. Value sales of CBD and other non-intoxicating cannabinoids products became stagn ... Read More
-
Cannabis in France
Cannabis in France While officially the value of the cannabis market in France reached EUR695 million in 2024, driven by CBD and other non-intoxicating cannabinoids, the overall market (including sales of illicit cannabis) is estimated at EUR6.7 billion. Illicit cannabis is estimated to account for ... Read More
-
Cannabis in Mexico
Cannabis in Mexico The outgoing administration of former President Andres Manuel López Obrador witnessed political stagnation: Euromonitor International's Cannabis in Mexico market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It p ... Read More
-
Cannabis in Chile
Cannabis in Chile Cannabis culture in Chile is at an intermediate stage of development compared to other countries in Latin America. Shortly after the decriminalisation of cannabis for medicinal use in 2016, the country experienced a proliferation of ""grow shops"" and home-growing practices aimed a ... Read More
-
Cannabis in Colombia
Cannabis in Colombia Although the world is making progress in the regulation of cannabis for adult use, in Colombia it continues to be a controversial issue because its consumption has been strongly linked to violence derived from drug trafficking. Although several bills have been proposed in Congre ... Read More
-
Cannabis in Germany
Cannabis in Germany In 2024, Germany has legalised cannabis consumption. Since cannabis is not listed as a narcotic drug anymore, access to medical cannabis has become easier too. Despite the legalisation aimed at combating the illicit market, the absence of legal production facilities and/or an inf ... Read More
-
Cannabis in Canada
Cannabis in Canada This report analyses the market for cannabis in Canada. For the purposes of the study, the market has been defined as follows: Euromonitor International's Cannabis in Canada market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a n ... Read More
-
Cannabis in Argentina
Cannabis in Argentina The Argentine economy is forecast to register a 3.8% decrease in gross domestic product (GDP) according to the International Monetary Fund (IMF), with inflation declining from 211% in 2023, to reach 150% at the end of 2024. A new President, Javier Milei, a libertarian economist ... Read More
-
Cannabis in the United Kingdom
Cannabis in the United Kingdom The UK cannabis market presents a mixed picture in 2024. Medical cannabis maintains its momentum, with value growth still in high double digits and another significant rise in patient numbers. Nevertheless, cost and accessibility issues continue to hamper uptake of med ... Read More
-
Cannabis in Australia
Cannabis in Australia The medicinal cannabis market in Australia is expected to be worth AUD582.1 million by 2024, serving 380,000 patients, up from 340,000 in 2023. As more individuals seek relief from anxiety and chronic pain, medical cannabis is becoming more widely known. Applications for specia ... Read More
-
Cannabis in Spain
Cannabis in Spain Spain is a well-developed and sophisticated cannabis market with strong growth potential for adult-use and medical purposes, and a professional cultivation model with a high level of expertise. While a legal framework for medical cannabis is on the horizon, the lack of political wi ... Read More
-
World Market for Cannabis
World Market for Cannabis Backed partly by existing legacy use, there is a broad-based growth narrative for legal cannabis. More geographies are moving from prohibition to controlling and taxing cannabinoid products. Consumers are turning to cannabis use in increasingly diverse parts of their lives ... Read More
-
Cannabis in Thailand
Cannabis in Thailand The cannabis market has experienced significant turmoil due to uncertainties arising from the actions of the Thai Government. Subsequently, there was a noticeable decline in consumer confidence in legal cannabis consumption in 2023. While demand appeared to be on the decline, a ... Read More
-
Cannabis in Poland
Cannabis in Poland Poland has become a strategic powerhouse for FMCG industries in Eastern Europe in the past two decades, and especially during the current geopolitical climate. The cannabis market is still in its infancy in Poland; however, a range of factors sets a stage for it to become one of t ... Read More
-
Cannabis in Brazil
Cannabis in Brazil Contrary to expectations, the national government did not advance hemp legislation for medical and industrial purposes in 2023. Instead, it opted to sidestep a potentially contentious debate, prioritising a comprehensive tax reformulation on its agenda. Despite this federal stance ... Read More
-
European Cannabis Regulation: Current State and Future Evolution
European Cannabis Regulation: Current State and Future EvolutionIn the last decades, the legislative landscape on cannabis has been constantly evolving in Europe. Countries have been going through legal developments with different speeds and directions, and ditto on a regional level. The legal incon ... Read More
-
Need States in Nicotine and Cannabis
Need States in Nicotine and Cannabis Increasingly substance-literate consumers are engaging with greater intensity with outcome-orientated positionings in cannabis and newer nicotine formats – a phenomenon which has clear consequences for the way in which manufacturers in these industries need to in ... Read More
-
Cannabis in Belgium
Cannabis in Belgium Cannabis in Belgium experienced continued rapid growth in 2023, primarily driven by CBD & other non-intoxicating cannabinoids, with the most popular format being CBD flower, followed by CBD oil (tinctures and sprays). Medical cannabis is also expanding, despite stringent regulati ... Read More
-
Cannabis in Israel
Cannabis in Israel In 2023, growth in the number of medical cannabis patients slowed significantly in Israel. In the first half of the year the number of medical patients grew by only 1,500; meanwhile, in 2021 monthly growth averaged 2,400, while in 2022 it was 1,220. This slow growth has led to cha ... Read More
-
Cannabis in the US
Cannabis in the US Cannabis in the US has seen a significant slowdown in growth in recent years, albeit with a still positive performance, and showing many indications of more robust growth over the forecast period. Although near-term federal legalisation is less likely, since it has not been a prio ... Read More
Research Assistance
